Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62019CN0102

    Case C-102/19: Request for a preliminary ruling from the Bundesverwaltungsgericht (Germany) lodged on 11 February 2019 — Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik Deutschland

    OJ C 172, 20.5.2019, p. 10–10 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    20.5.2019   

    EN

    Official Journal of the European Union

    C 172/10

    Request for a preliminary ruling from the Bundesverwaltungsgericht (Germany) lodged on 11 February 2019 — Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik Deutschland

    (Case C-102/19)

    (2019/C 172/12)

    Language of the case: German

    Referring court

    Bundesverwaltungsgericht

    Parties to the main proceedings

    Applicant: Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG

    Defendant: Bundesrepublik Deutschland

    Questions referred

    1.

    Does Article 69 of Directive 2001/83/EC (1) make exhaustive provision with respect to the permissible content of package leaflets for the medicinal products referred to in Article 14(1) or may other information within the meaning of Article 62 of Directive 2001/83/EC be included?

    2.

    May dosage schedules for the medicinal products referred to in Article 14(1) of Directive 2001/83/EC constitute information which is useful to the patient within the meaning of Article 62 of Directive 2001/83/EC?

    (1)  Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67), as amended by Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 (OJ 2012 L 299, p. 1).

    Top